Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/2012
04/04/2012CN102399260A 氨基噻唑衍生物以及其作为抗菌剂的应用 Amino thiazole derivatives and their use as an antibacterial agent,
04/04/2012CN102153623B 具有溶血栓活性的化合物、其制备方法和应用 Compounds having thrombolytic activity, their preparation and use
04/04/2012CN101157720B 作为丝氨酸蛋白酶抑制剂的模板固定肽模拟物 Fixed peptide mimetic as a template the serine protease inhibitor
04/03/2012USRE43298 Peptides as NS3-serine protease inhibitors of hepatitis C virus
04/03/2012US8148493 Method for inhibiting “melanoma inhibitory activity” MIA
04/03/2012US8148334 Peptides with capacity for binding with interleukine 10 (IL-10)
04/03/2012US8148320 Peptide inhibitors of ABL kinases
04/03/2012US8147838 Peptide
04/03/2012US8147837 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation
04/03/2012US8147819 Peptides for active anti-cytokine immunization
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
03/2012
03/29/2012WO2012040259A2 Modified compstatin with improved stability and binding properties
03/29/2012WO2012038932A2 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
03/29/2012WO2012038929A1 Cosmetic use of dermicidin, and analogues or fragments thereof
03/29/2012WO2012038486A1 Method for obtaining a purified hbha polypeptide or fragment thereof
03/29/2012WO2012037778A1 Polypeptide tf1 for inhibiting type 2 shiga toxin activity, encoding gene for same and use thereof
03/29/2012WO2012006732A8 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
03/29/2012US20120077958 Multimodal Imaging of Fibrin
03/29/2012US20120077957 Lactam-Bridged Melanocortin Receptor-Specific Peptides
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077749 Biologically Active Peptides
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120076811 Immunodominant compositions and methods of use therefor
03/29/2012US20120076810 Vaccinia virus polypeptides
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012CA2813049A1 Modified compstatin with improved stability and binding properties
03/28/2012EP2434014A1 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
03/28/2012EP2433953A1 Cell membrane-permeable peptides
03/28/2012EP2433639A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
03/28/2012EP2432801A2 Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
03/28/2012EP2432800A2 Marked peptides and use thereof for assaying circulating irap
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012CN102391365A A group of new antibiotic peptides, preparation method thereof and use thereof
03/28/2012CN102391364A New antibacterial peptides as well as preparation method and application of the same
03/28/2012CN102391363A Method for extracting enramycin
03/28/2012CN102391362A Group of animal-derived cationic antibacterial peptides and its application
03/28/2012CN102391361A Chickpea peptide with antioxidation effect and separation and purification method and application
03/28/2012CN102391360A Small peptide capable of resisting thrombosis and platelet aggregation
03/28/2012CN102391168A Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
03/28/2012CN101624420B Group of novel cyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof
03/28/2012CN101318994B Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
03/28/2012CN101270152B Peptide medicament series for accelerating medulla hematopoiesis cell proliferation
03/27/2012US8142786 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein
03/27/2012US8142764 Synthetic biofilm-inhibiting peptides
03/27/2012CA2540917C Polyarginine-modified liposome having nuclear entry ability
03/27/2012CA2534224C Preparation of somatostatin peptides
03/27/2012CA2485698C Peptide amidation process
03/27/2012CA2471687C Microwave-assisted peptide synthesis
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/22/2012WO2012037498A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
03/22/2012WO2012036437A2 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
03/22/2012WO2012036094A1 Lung cancer identification marker
03/22/2012WO2012034188A1 Peptide inhibitors of cd40l signaling and uses therefor
03/22/2012US20120071628 Topical therapeutic agent for ophthalmic diseases comprising compound capable of binding specifically to dna sequence
03/22/2012US20120071399 Sulfation of wnt pathway proteins
03/22/2012US20120071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
03/22/2012US20120071337 Methods
03/22/2012US20120071334 Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
03/22/2012US20120070897 Method For Enucleating Nucleated Erythrocyte, And Enucleation Inducer
03/22/2012US20120070875 Amino Acid Sequences which Enhance Peptide Conjugate Solubility
03/22/2012US20120070854 HNRNP A3 Related Peptides and Use Thereof for Diagnosis of Rheumatoid Arthritis
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070457 Polypeptides from neisseria meningitidis
03/22/2012US20120070455 Influenza vaccine
03/22/2012US20120070416 Macrocyclic Proline Derived HCV Serine Protease Inhibitors
03/22/2012DE19735587B4 Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens Peptide having radioprotective effect, cosmetic or pharmaceutical composition containing it, for this coding nucleic acid, production processes for this peptide and use as radioprotektives agent
03/22/2012CA2811295A1 Broad spectrum antibiotic arylomycin analogs
03/21/2012EP2431381A2 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites
03/21/2012EP2431055A1 Conjugates of membrane translocating agents and pharmaceutically active agents
03/21/2012EP2431052A1 Protein for the immunocastration for mammals
03/21/2012EP2431048A2 Phenolic binding peptides
03/21/2012EP2430162A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
03/21/2012EP2430039A1 Ttk peptides and vaccines including the same
03/21/2012EP2430038A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
03/21/2012EP2429565A2 Peptides and aptamers for targeting of neuron or nerves
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012CN1865280B Solid phase polypeptide synthesis preparation method for leuprorelin
03/21/2012CN102388060A Actagardine derivatives
03/21/2012CN102387813A Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
03/21/2012CN102382854A Hexameric prokaryotic expression vector of Cyprinus carpiovar Jian gonadotrophin-releasing hormone gene, and establishing method and application thereof
03/21/2012CN102382839A Anti-herpes simplex virus (HSV) active polypeptide of Tibetan Pi scorpion and application thereof
03/21/2012CN102382177A Method for extracting, separating and purifying enramycin
03/21/2012CN102382176A Oral cavity cariogenic bacterium-resisting polypeptide Pm11 and preparation method thereof
03/21/2012CN102382175A Polypeptide for specifically targeting lung cancer cell, and preparation method and application thereof
03/21/2012CN102382174A Polypeptide Pm14 for resisting oral cariogenic bacteria and preparation method thereof
03/21/2012CN102382173A Oligopeptide C and antibacterial application thereof
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102382171A Polypeptide for inhibiting hepatitis C virus infected cell and application thereof
03/21/2012CN102382170A Method for preparation of protease inhibitors and intermediates
03/21/2012CN102380094A Application of specific polypeptide to preparation of rabies vaccine
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138304 Neural regeneration peptides and formulations thereof
03/20/2012US8138153 Potassium channel modulator peptide
03/20/2012US8138140 Self-assembling peptide amphiphiles and related methods for growth factor delivery
03/20/2012CA2514507C Methods and compositions for the treatment of gastrointestinal disorders
03/20/2012CA2446872C Immune-modulating peptide
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 423